MAAT INDEX

CLAIM #15020 · Colgate-Palmolive Company (CL) · 2025Q4 earnings call · Jan 30, 2026

Our anticipation is that will get a little better. But as I mentioned, we're not assuming the U.S. will get significantly better, at least in the next couple of quarters.

Noel Wallace · CEO

Verdict
PENDING
Direction
up
Magnitude
Due
Jul 31, 2026
Metric
company_kpi
Intensity
hedged

How to check this claim

Look at: U.S. segment organic/category volume growth rate, as reported quarterly

It came true if: U.S. volume trend improves modestly versus current negative levels but does not turn significantly positive over the next two quarters

Where: Company quarterly earnings release and management commentary on U.S. segment organic sales/volume (10-Q / earnings call)

Knowable after: 2026-07-31

In context

early, we're pleased with the -- as you said, the momentum exiting the year. On an underlying basis, excluding private label, organic in excess of 3%. So a good number that we think sets us up well, but the environment continues to be very challenging and very volatile. Overall, it seems like the categories have stabilized at the lower rate than our historical assumptions, as you well know, probably in that 1.5% to 2.5% as we showed in the prepared commentary. We're seeing a lot of month-to-month swings in the U.S., which you can see in the candidate, obviously, plus we continue to see some downward pressure on inventories as category slow. The volume is the particularly more acute issue in the U.S. where we've seen on our core categories some of the volumes go negative in the categories. Our anticipation is that will get a little better. But as I mentioned, we're not assuming the U.S. will get significantly better, at least in the next couple of quarters. On an underlying basis, though, we think North America was actually a little better for us this quarter, but still not where we need it to be, as I've discussed before. We do things with a better -- with a little better thinking in 2026 versus our strategy in '25, we've got easier comps, we've got a much stronger innovation pipeline and the execution is improving, and we certainly saw that improve as we went through the back half of the year. If I go on to some of the other regions, as expected, Europe is seeing less pricing than before. Volume is maybe slightly better than we were expecting. Western Europe better, which was good to see, but some continued weakness, particularly in Eastern Europe and specifically calling out Poland in that regard. Latin America was very encouraging with M

Verify independently

SEC filings for CL · Quote is verbatim from the 2025Q4 earnings call.